Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mullan

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Neuroscience Letters|December 29, 1998
Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivoZ Suo, J Humphrey, A Kundtz, et al.
Brain Research|January 23, 1999
Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhageG C Su, G W Arendash, R N Kalaria, et al.
American Journal of Medical Genetics|July 25, 1997
APOE is linked to Alzheimer's disease in a large pedigreeX Cai, D Fallin, J Stanton, et al.
Neuroscience Letters|July 10, 1999
Intravascular beta-amyloid infusion increases blood pressure: implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's diseaseG W Arendash, G C Su, F C Crawford, et al.
Annals of the New York Academy of Sciences|May 20, 2000
A beta vasoactivity in vivoZ Suo, G Su, A Placzek, et al.
Annals of Neurology|May 11, 2000
No association between the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United StatesF Crawford, M Freeman, L Abdullah, et al.
Nature Genetics|August 1, 1992
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloidM Mullan, F Crawford, K Axelman, et al.
Nature|April 2, 1992
Alzheimer's--a correctionF Crawford, M C Chartier-Harlin, M Mullan, et al.
Neuroscience Letters|August 26, 1999
The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sampleF Crawford, T Town, M Freeman, et al.
American Journal of Medical Genetics|August 14, 1995
Occurrence of the Cys311 DRD2 variant in a pedigree multiply affected with panic disorderF Crawford, J Hoyne, P Diaz, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Neuroscience Letters|December 29, 1998
Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivoZ Suo, J Humphrey, A Kundtz, et al.
Brain Research|January 23, 1999
Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhageG C Su, G W Arendash, R N Kalaria, et al.
American Journal of Medical Genetics|July 25, 1997
APOE is linked to Alzheimer's disease in a large pedigreeX Cai, D Fallin, J Stanton, et al.
Neuroscience Letters|July 10, 1999
Intravascular beta-amyloid infusion increases blood pressure: implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's diseaseG W Arendash, G C Su, F C Crawford, et al.
Annals of the New York Academy of Sciences|May 20, 2000
A beta vasoactivity in vivoZ Suo, G Su, A Placzek, et al.
Annals of Neurology|May 11, 2000
No association between the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United StatesF Crawford, M Freeman, L Abdullah, et al.
Nature Genetics|August 1, 1992
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloidM Mullan, F Crawford, K Axelman, et al.
Nature|April 2, 1992
Alzheimer's--a correctionF Crawford, M C Chartier-Harlin, M Mullan, et al.
Neuroscience Letters|August 26, 1999
The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sampleF Crawford, T Town, M Freeman, et al.
American Journal of Medical Genetics|August 14, 1995
Occurrence of the Cys311 DRD2 variant in a pedigree multiply affected with panic disorderF Crawford, J Hoyne, P Diaz, et al.
Pageof 13